publicações selecionadas
- Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Primary African Isolates
- Análise da Expressão de miRNAs em Subpopulações de Linfócitos T em Pacientes com Esclerose Múltipla.
- RNA mensageiro codificador da proteína hsp65 de Mycobacterium leprae como uma nova estratégia vacinal no combate da tuberculose experimental.
- Avaliaçao do uso de RNA mensagerio como estratégia vacinal no modelo da tuberculose experimental
- Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice
- Sequence evaluation and comparative analysis of novel assays for intact proviral HIV-1 DNA
- Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption
- Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
- Evolution of antibody immunity to SARS-CoV-2
- Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients
- COVID-19 antibody development fueled by HIV-1 broadly neutralizing antibody research
- Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
- Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies
- Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo
- Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants
- Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaques
- Análise da expressão de miRNAs em subpopulações de linfócitos T em pacientes com Esclerose Múltipla (Doutorado Sanduiche)
- Enhanced SARS-CoV-2 neutralization by dimeric IgA
- Convergent antibody responses to SARS-CoV-2 in convalescent individuals
